Candriam S.C.A. Nkarta, Inc. Transaction History

Candriam S.C.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$7.77 - $19.44 $482,198 - $1.21 Million	-62,059 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.66 - $14.99 $51,414 - $88,995	-5,937 Reduced 8.73%	62,059 $706,000
Q3 2021 Nov 09, 2021	BUY	$26.67 - $38.76 $1.81 Million - $2.64 Million	67,992 Added 1699800.0%	67,996 $1.89 Million
Q2 2021 Jul 20, 2021	SELL	$23.94 - $36.68 $1.61 Million - $2.46 Million	-67,142 Reduced 99.99%	4 $0
Q4 2020 Jan 22, 2021	BUY	$27.03 - $75.62 $1.81 Million - $5.08 Million	67,146 New	67,146 $4.13 Million

130

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $131M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.